Benitec has the IP to be a biotec major, its recent board appointment of Kevin Buchi demonstrates industry heavy weights agree he also has bought hundreds of thousands of dollars of stock, this is extremely bullish. Remember Mesoblast was looking at an equal merger in 2009 the largest shareholders shook hands on it, they may well be equals in market capitalisation sooner than what would seem possible.
